PRISM MarketView

Vocodia IPO Bolstered by Insider Investments

New York, March 26, 2024 - PRISM MarketView - AI software company, Vocodia Holdings’ (CBOE: VHAI) senior management team has further demonstrated its conviction in the company’s strategic direction with significant investments in Vocodia’s February 2024 initial public of...

26 March 2024

PRISM Oil & Gas Spotlight: Independence Contract Drilling

New York, March 26, 2024 - PRISM MarketView - Independence Contract Drilling (NYSE: ICD) is leading the PRISM Emerging Oil & Gas Index on Tuesday afternoon with gains of 10.29%. The company has performed strongly over the past seven days after announcing that its Str...

26 March 2024

Talos Energy Divests Carbon Capture Subsidiary in $148M Deal

New York, March 26, 2024 - PRISM MarketView - Innovative energy company, Talos Energy (NYSE: TALO), will sell its wholly owned subsidiary, Talos Low Carbon Solutions, to TotalEnergies E&P USA for a purchase price of $125 million plus customary reimbursements, adjustm...

26 March 2024

PRISM AdTech and Media Index Laggard Cardlytics (CDLX) Falls on Senior Notes Offering, Down ~30%

New York, March 26, 2024 - PRISM MarketView - Today Cardlytics, Inc. (CDLX) is trailing the PRISM AdTech and Media Index on its announcement to propose a convertible senior notes offering, sending shares tumbling down ~30%. The announcement of its intention to offer inc...

26 March 2024

Everyone Gets a Chatbot! Veritone (VERI) Launches “Ask Veri”, Stock Moving Up ~18%

New York, March 26, 2024 - PRISM MarketView - Leading the PRISM AdTech and Media Index, Veritone, Inc. (VERI) the AI and media solutions company, announced the launch of its new conversational intelligence solution, Ask Veri that empowers its Veritone Digital Media Hub....

26 March 2024

FDA Clearance for Neuronetics’ Adjunct Treatment for Depression in Adolescents

New York, March 26, 2024 - PRISM MarketView - Medical technology company, Neuronetics, Inc. (Nasdaq: STIM), has received clearance from the FDA for its NeuroStar Advanced Therapy for use as an adjunct for the treatment of major depressive disorder (MDD) in adolescent pa...

26 March 2024

AIM ImmunoTech Publishes Early Access Data in Prestigious Oncology Journal

New York, March 26, 2024 - PRISM MarketView - Immuno-pharma company, AIM ImmunoTech (NYSE American: AIM) has published a new data analysis from a long-term Early Access Program studying the company’s drug Ampligen® (rintatolimod) for the treatment of advanced pancreatic ...

26 March 2024

Seelos Misses Endpoints in Blow to ALS Community

New York, March 25, 2024 - PRISM MarketView - Biopharmaceutical company, Seelos Therapeutics (Nasdaq: SEEL) has missed primary and secondary endpoints in its Phase 2/3 HEALEY ALS Platform trial of SLS-005 in a blow to the ALS community. The company’s shares dropped by mo...

25 March 2024

An Investment Injection for a Fuel Injection-Less Company, Lucid Group (LCID) Receives $1Bn

New York, March 25, 2024 - PRISM MarketView - While the EV sector faces hardships and names such as Fisker (FSR) struggle today, Lucid Group, Inc. (LCID) has announced some positive news, sending its share price up ~8% and pushing its daily volume to ~82M shares. The com...

25 March 2024

Fisker (FSR) Has Become Fiscally Frantic. Deal Talks with Large Automaker End, Down ~28%

New York, March 25, 2024 - PRISM MarketView - PRISM EV Index laggard and electric vehicle automaker, Fisker Inc. (FSR) has reported that its discussions with large automaker have ended. As the company shares have fallen ~28%, its chances of bankruptcy have increased. Ove...

25 March 2024